A month has gone by since the last earnings report for Pfizer (PFE). Shares have lost about 1.9% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up to ...

The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the ...

Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine ...

There is no better period, given the volatility in the markets today, to rotate assets into dividend stocks, said Steven ...

Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility ...

Uniondale-based McHugh Furnishings, a provider of specialty furnishings for education, healthcare, entertainment and ...

The pharmaceutical industry is evolving continuously with the advancements in drug discovery with Artificial Intelligence (AI ...

A German court ruled that BioNTech (BNTX) and Pfizer (PFE) have to pay Moderna damages because they infringed on Moderna ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best affordable dividend stocks to buy according to hedge funds. In 2024, several major tech ...